Antineoplastic agents: Poland public contracts since 2024

Updated 12 October 2026 · all lines

Antineoplastic agents: Poland public contracts since 2024. Since January 2024 the line carries 1,003 award notices from 54 buyers. 377 suppliers share it. 293 in 2024. 417 in 2025. 293 in the first 9 months of 2026. 137 of them had no award notice in the register from November 2023 to 2024.

Assay record ASY-PL-0NLZDFK00O · Cite as: Assay Systems, “Antineoplastic agents: Poland public contracts since 2024”, https://assay-systems.com/register/pl/line/antineoplastic-agents/

The line

Since January 2024 the line carries 1,003 award notices from 54 buyers. 377 suppliers share it.

293 in 2024. 417 in 2025. 293 in the first 9 months of 2026.

137 of them had no award notice in the register from November 2023 to 2024.

Suppliers in the line, by award notices since 2024

58 more suppliers in the line are not listed here, because their register name may be the name of a private person.

The extract for this line

Names every buyer behind the figures and, for each award notice, the supplier, the award date, the notice number and the value where one is disclosed, and the notices behind every figure.

Largest suppliers in the line

Share of the line held by each of its largest suppliers, by number of award notices, in the TED register for Poland.

Urtica Sp. z o.o.61.7%Salus International Sp. z o.o.42.8%Asclepios S.A.40.2%Farmacol-Logistyka Sp. z o.o.35.5%Tramco Sp. z o.o.26.5%Bialmed Sp. z o.o.24.3%Roche Polska Sp. z o.o.23.8%Komtur Polska Sp. z o.o.23.7%AstraZeneca Kft.22.1%Fresenius Kabi Polska Sp. z o.o.18.5%

All suppliers in Poland, A to Z

Source: contract award notices for Poland in Tenders Electronic Daily (TED), Publications Office of the European Union, ted.europa.eu, reusable for commercial purposes under Commission Decision 2011/833/EU; notices from November 2023, when TED began to publish the winning supplier, to 30 September 2026, accessed 11 October 2026.Assay Systems has changed the data.